Literature DB >> 33483533

Genetic deletion of Abcc6 disturbs cholesterol homeostasis in mice.

Bettina Ibold1, Janina Tiemann1, Isabel Faust1, Uta Ceglarek2, Julia Dittrich2, Theo G M F Gorgels3,4, Arthur A B Bergen4,5, Olivier Vanakker6, Matthias Van Gils6, Cornelius Knabbe1, Doris Hendig7.   

Abstract

Genetic studies link adenosine triphosphate-binding cassette transporter C6 (ABCC6) mutations to pseudoxanthoma elasticum (PXE). ABCC6 sequence variations are correlated with altered HDL cholesterol levels and an elevated risk of coronary artery diseases. However, the role of ABCC6 in cholesterol homeostasis is not widely known. Here, we report reduced serum cholesterol and phytosterol levels in Abcc6-deficient mice, indicating an impaired sterol absorption. Ratios of cholesterol precursors to cholesterol were increased, confirmed by upregulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase (Hmgcr) expression, suggesting activation of cholesterol biosynthesis in Abcc6-/- mice. We found that cholesterol depletion was accompanied by a substantial decrease in HDL cholesterol mediated by lowered ApoA-I and ApoA-II protein levels and not by inhibited lecithin-cholesterol transferase activity. Additionally, higher proprotein convertase subtilisin/kexin type 9 (Pcsk9) serum levels in Abcc6-/- mice and PXE patients and elevated ApoB level in knockout mice were observed, suggesting a potentially altered very low-density lipoprotein synthesis. Our results underline the role of Abcc6 in cholesterol homeostasis and indicate impaired cholesterol metabolism as an important pathomechanism involved in PXE manifestation.

Entities:  

Year:  2021        PMID: 33483533     DOI: 10.1038/s41598-021-81573-1

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  45 in total

1.  ABCC6 gene polymorphism associated with variation in plasma lipoproteins.

Authors:  J Wang; S Near; K Young; P W Connelly; R A Hegele
Journal:  J Hum Genet       Date:  2001       Impact factor: 3.172

2.  Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease.

Authors:  Gina M Peloso; Serkalem Demissie; Dorothea Collins; Daniel B Mirel; Stacey B Gabriel; L Adrienne Cupples; Sander J Robins; Ernst J Schaefer; Margaret E Brousseau
Journal:  J Lipid Res       Date:  2010-09-20       Impact factor: 5.922

3.  Pseudoxanthoma elasticum and statin prophylaxis.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2013-10       Impact factor: 4.599

Review 4.  PXE, a Mysterious Inborn Error Clarified.

Authors:  Piet Borst; András Váradi; Koen van de Wetering
Journal:  Trends Biochem Sci       Date:  2018-11-13       Impact factor: 13.807

5.  Atorvastatin counteracts aberrant soft tissue mineralization in a mouse model of pseudoxanthoma elasticum (Abcc6⁻/⁻).

Authors:  Haitao Guo; Qiaoli Li; David W Chou; Jouni Uitto
Journal:  J Mol Med (Berl)       Date:  2013-06-27       Impact factor: 4.599

6.  Disruption of Abcc6 in the mouse: novel insight in the pathogenesis of pseudoxanthoma elasticum.

Authors:  Theo G M F Gorgels; Xiaofeng Hu; George L Scheffer; Allard C van der Wal; Johan Toonstra; Paulus T V M de Jong; Toin H van Kuppevelt; Christiaan N Levelt; Anneke de Wolf; Willem J P Loves; Rik J Scheper; Ron Peek; Arthur A B Bergen
Journal:  Hum Mol Genet       Date:  2005-05-11       Impact factor: 6.150

7.  Ectopic calcification in pseudoxanthoma elasticum responds to inhibition of tissue-nonspecific alkaline phosphatase.

Authors:  Shira G Ziegler; Carlos R Ferreira; Elena Gallo MacFarlane; Ryan C Riddle; Ryan E Tomlinson; Emily Y Chew; Ludovic Martin; Chen-Ting Ma; Eduard Sergienko; Anthony B Pinkerton; José Luis Millán; William A Gahl; Harry C Dietz
Journal:  Sci Transl Med       Date:  2017-06-07       Impact factor: 17.956

8.  Molecular docking simulations provide insights in the substrate binding sites and possible substrates of the ABCC6 transporter.

Authors:  Mohammad Jakir Hosen; Abdullah Zubaer; Simrika Thapa; Bijendra Khadka; Anne De Paepe; Olivier M Vanakker
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240

9.  ABCC6- a new player in cellular cholesterol and lipoprotein metabolism?

Authors:  Patricia Kuzaj; Joachim Kuhn; Mareike Dabisch-Ruthe; Isabel Faust; Christian Götting; Cornelius Knabbe; Doris Hendig
Journal:  Lipids Health Dis       Date:  2014-07-27       Impact factor: 3.876

Review 10.  Pseudoxanthoma elasticum.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2017-05-10       Impact factor: 4.123

View more
  5 in total

1.  The Expression Level of ABCC6 Transporter in Colon Cancer Cells Correlates with the Activation of Different Intracellular Signaling Pathways.

Authors:  Vittorio Abruzzese; Caecilia H C Sukowati; Claudio Tiribelli; Ilenia Matera; Angela Ostuni; Faustino Bisaccia
Journal:  Pathophysiology       Date:  2022-05-12

Review 2.  ABCC6, Pyrophosphate and Ectopic Calcification: Therapeutic Solutions.

Authors:  Briana K Shimada; Viola Pomozi; Janna Zoll; Sheree Kuo; Ludovic Martin; Olivier Le Saux
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

3.  ABCC6 Knockdown Fuels Cell Proliferation by Regulating PPARα in Hepatocellular Carcinoma.

Authors:  Zhicong Zhao; Zhenjun Zhao; Jianye Wang; He Zhang; Zhifeng Xi; Qiang Xia
Journal:  Front Oncol       Date:  2022-02-24       Impact factor: 6.244

4.  Targeting ABCC6 in Mesenchymal Stem Cells: Impairment of Mature Adipocyte Lipid Homeostasis.

Authors:  Ricarda Plümers; Michel R Osterhage; Christopher Lindenkamp; Cornelius Knabbe; Doris Hendig
Journal:  Int J Mol Sci       Date:  2022-08-16       Impact factor: 6.208

Review 5.  Therapy of Pseudoxanthoma Elasticum: Current Knowledge and Future Perspectives.

Authors:  Max Jonathan Stumpf; Nadjib Schahab; Georg Nickenig; Dirk Skowasch; Christian Alexander Schaefer
Journal:  Biomedicines       Date:  2021-12-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.